Showing results (41-50 of 96) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies GroupGordon J Rustin, Graham M Mead, Sally P Stenning, et al.European Urology|December 4, 2014
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinomaThomas Geldart, John Chester, Angela Casbard, et al.The Lancet. Oncology|January 2, 2013
Stereotactic body radiotherapy for oligometastasesAlison C Tree, Vincent S Khoo, Rosalind A Eeles, et al.The British Journal of Radiology|January 25, 2019
Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapyAngela U Pathmanathan, Helen A McNair, Maria A Schmidt, et al.Journal of the National Cancer Institute|May 17, 2007
Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873)Malcolm D Mason, Matthew R Sydes, John Glaholm, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2007
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397)David P Dearnaley, Matthew R Sydes, Ruth E Langley, et al.International Journal of Radiation Oncology, Biology, Physics|August 21, 2013
Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004)Robert A Huddart, Emma Hall, Syed A Hussain, et al.Cancer Medicine|September 6, 2025
Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer SurvivorsSwetha Nakshatri, Paul C Dinh, Lawrence H Einhorn, et al.BJU International|April 29, 2017
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomyRobert A Huddart, Alison Birtle, Lauren Maynard, et al.Nature Genetics|June 15, 2010
Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancerClare Turnbull, Elizabeth A Rapley, Sheila Seal, et al.Pageof 10